Massachusetts Institute Of Technology

Massachusetts Institute Of Technology increased its stake in Panacea Biotec from 1.12% to 1.71%, raising its shareholding from 6,85,000 to 10,50,000 shares. The value of the additional 3,65,000 shares is ₹16.86 Cr at ₹461.95 apiece.

Massachusetts Institute Of Technology, which last reported a 1.56 percent stake in Indef Manufacturing Limited, no longer appears on the company's disclosed shareholder list, indicating either a complete exit or a reduction in its holding below the 1 percent disclosure threshold.

Massachusetts Institute Of Technology acquired 16.4 lakh shares, a 1.53% stake, in Renaissance Global for ₹19.76 Cr at ₹120.50 apiece in a new position during a rights issue context.

Massachusetts Institute Of Technology initiated a new position in Gujarat Ambuja Exports Limited, acquiring 54.61 lakh shares, representing a 1.19% stake, valued at approximately ₹79.68 crore at a share price of ₹145.90.

Massachusetts Institute Of Technology increased its stake in Medi Assist Healthcare Services from 3.87% to 4.64%, purchasing 577,500 shares. This transaction follows a previous preferential allotment in October 2025 where Massachusetts Institute of Technology, along with 238 Plan Associates LLC, invested ₹198 crore in Medi Assist Healthcare Services at ₹535 per share.

Massachusetts Institute Of Technology initiated a new position in Aavas Financiers with 8,70,411 shares, representing a 1.10% stake, valued at ₹131.06 crore based on the share price of ₹1505.30.

Massachusetts Institute Of Technology bought 16.4 lakh shares of Renaissance Global Limited for ₹17.48 Cr at ₹106.58 apiece in a bulk deal.

Massachusetts Institute Of Technology bought 38,000 shares of Medi Assist Healthcare Services Limited for ₹1.26 Cr at ₹330.85 apiece via an open market purchase, increasing its stake from 3.87% to 3.92%. Along with 238 Plan Associates LLC, Massachusetts Institute Of Technology crossed the 5% disclosure threshold.